Logo Logo
Switch Language to German
Barthel, Henryk; Meyer, Philipp T.; Drzezga, Alexander; Bartenstein, Peter; Boecker, Henning; Brust, Peter; Buchert, Ralph; Coenen, Heinz. H.; Fougere, Christian la; Gründer, Gerhard; Grünwald, Frank; Krause, Bernd J.; Kuwert, Torsten; Schreckenberger, Matthias; Tatsch, Klaus; Langen, Karl-Josef; Sabri, Osama (2016): Beta-Amyloid-PET-Bildgebung des Gehirns. DGN-Handlungsempfehlung. In: Nuklearmedizin-Nuclear Medicine, Vol. 55, No. 4: pp. 129-137
Full text not available from 'Open Access LMU'.


Recently, a number of positron emission tomography (PET) radiotracers have been approved for clinical use. These tracers target cerebral beta-amyloid (AP) plaques, a hallmark of Alzheimer's disease. Increasing use of this method implies the need for respective standards. This German Society of Nuclear Medicine guideline describes adequate procedures for A beta plaque PET imaging. It not only discusses the tracers used for that purpose, but also lists measures for correct patient preparation, image data generation, processing, analysis and interpretation. With that, this "S1" category (according to the German Association of the Scientific Medical Societies standard) guideline aims at contributing to quality assurance of nuclear imaging in Germany.